BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Skin cancer AND CASP8, ALPS2B, 841, ENSG00000064012, MGC78473, CAP4, MACH, MCH5, FLICE AND Prognosis
11 results:

  • 1. Safety and Efficacy of Lenvatinib in Very Old Patients with Unresectable Hepatocellular Carcinoma.
    Camera S; Rimini M; Rossari F; Tada T; Suda G; Shimose S; Kudo M; Yoo C; Cheon J; Finkelmeier F; Lim HY; Presa J; Masi G; Bergamo F; Salani F; Marseglia M; Amadeo E; Vitiello F; Kumada T; Sakamoto N; Iwamoto H; Aoki T; Chon HJ; Himmelsbach V; Iavarone M; Cabibbo G; Montes M; Foschi FG; Vivaldi C; Lonardi S; Sho T; Niizeki T; Nishida N; Steup C; Hirooka M; Kariyama K; Tani J; Atsukawa M; Takaguchi K; Itobayashi E; Fukunishi S; Tsuji K; Ishikawa T; Tajiri K; Ochi H; Yasuda S; Toyoda H; Ogawa C; Nishimura T; Hatanaka T; Kakizaki S; Shimada N; Kawata K; Hiraoka A; Tada F; Ohama H; Nouso K; Morishita A; Tsutsui A; Nagano T; Itokawa N; Okubo T; Imai M; Kosaka H; Naganuma A; Koizumi Y; Nakamura S; Kaibori M; Iijima H; Hiasa Y; Persano M; Foti S; Piscaglia F; Scartozzi M; Cascinu S; Casadei-Gardini A
    Target Oncol; 2024 Jan; 19(1):29-39. PubMed ID: 38252195
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Evaluation of HER-2 positive breast cancer treated with dual-targeted treatment of trastuzumab plus pertuzumab.
    Jiang S; Geng S; Gao X; Liu T; Luo X; Wang N; Shi N; Dong M
    Immunopharmacol Immunotoxicol; 2023 Oct; 45(5):616-625. PubMed ID: 36809922
    [No Abstract]    [Full Text] [Related]  

  • 3. Road to Metastasis: The TWEAK Pathway as a Discriminant between Metastasizing and Non-Metastasizing Thick Melanomas.
    Güvenç C; Antoranz A; Szumera-Ciećkiewicz A; Teterycz PP; Rutkowski PR; Rawson RV; Scolyer RA; Thompson JF; Newton-Bishop J; Stas M; Boecxstaens V; Bechter O; Vercauteren J; Garmyn M; van den Oord J; Bosisio FM
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638912
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. A construction and comprehensive analysis of ceRNA networks and infiltrating immune cells in papillary renal cell carcinoma.
    Fan Y; Dai F; Yuan M; Wang F; Wu N; Xu M; Bai Y; Liu Y
    Cancer Med; 2021 Nov; 10(22):8192-8209. PubMed ID: 34598322
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Primary cutaneous B-cell lymphoma: A single-center 5-year experience.
    Jacob LA; Asati V; Lakshmaiah KC; Govind BK; Lokanatha D; Babu SM; Lokesh KN; Rudresh AH; Rajeev LK; Mulchandani NJ; Anand A; Koppaka D; Mysore SN
    Indian J Cancer; 2018; 55(2):134-137. PubMed ID: 30604723
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. [Cetuximab in head and neck squamous cell carcinoma: a systematic review and Meta-analysis].
    Song Q; Li X; Li B
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Jan; 29(1):67-75. PubMed ID: 25966559
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Systemic treatment of metastatic uveal melanoma: review of literature and future perspectives.
    Buder K; Gesierich A; Gelbrich G; Goebeler M
    Cancer Med; 2013 Oct; 2(5):674-86. PubMed ID: 24403233
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. [Descriptive epidemiology of cancers in Cote d'Ivoire].
    Effi AB; Koffi KE; Aman NA; Doukouré B; N'dah KJ; Koffi KD; Kouyaté M; Koui BB; Hondé M; Diomandé MI
    Bull Cancer; 2013 Feb; 100(2):119-25. PubMed ID: 23406565
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Expression of c-FLIP in malignant melanoma, and its relationship with the clinicopathological features of the disease.
    Tian F; Lu JJ; Wang L; Li L; Yang J; Li Y; Liu YQ; Shen GX; Tu YT; Tao J
    Clin Exp Dermatol; 2012 Apr; 37(3):259-65. PubMed ID: 22103668
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Surgical closure of chest wall in noninflammatory locally advanced breast carcinoma with ulceration of the skin.
    Martella S; Caliskan M; Brenelli FP; Rossetto F; Aparecida De Oliveira H; De Brito Lima LN; Chifu C; Rodriguez-Fernandez J; Petit JY; Luini A
    Breast J; 2008; 14(4):345-52. PubMed ID: 18540959
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Non-melanoma skin cancer may be a marker of poor prognosis in patients with non-Hodgkin's lymphoma.
    Hjalgrim H; Frisch M; Storm HH; Glimelius B; Pedersen JB; Melbye M
    Int J Cancer; 2000 Mar; 85(5):639-42. PubMed ID: 10699942
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.